Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon

Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon

Objective: The pathophysiology of the slow coronary flow (SCF) phenomenon is still unclear. The two most frequently cited mechanisms of SCF are endothelial dysfunction and subclinical diffuse atherosclerosis. The aim of this study was to investigate the relation of SCF to serum endocan levels which...

Full description

Bibliographic Details
Main Authors: Serhat Sığırcı, Remzi Sarıkaya, Kudret Keskin, Süleyman Sezai Yıldız, Saadet Pilten Güzel, Gökhan Çetinkal, İmran Önur, Kadriye Orta Kılıçkesmez
Format: Article
Language:English
Published: KARE Publishing 2019-06-01
Series:Türk Kardiyoloji Derneği Arşivi
Subjects:
endothelial dysfunction
diffuse atherosclerosis
slow flow pathophysiology
adipokine
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-27708

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-27708

Similar Items